Cognition Therapeutics Statistics

Total Valuation

CGTX has a market cap or net worth of $72.91 million. The enterprise value is $38.90 million.

Market Cap	72.91M
Enterprise Value	38.90M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, before market open.

Earnings Date	Aug 6, 2024
Ex-Dividend Date	n/a

Share Statistics

CGTX has 40.06 million shares outstanding. The number of shares has increased by 15.95% in one year.

Shares Outstanding	40.06M
Shares Change (YoY)	+15.95%
Shares Change (QoQ)	+8.73%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	34.61%
Float	33.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.53
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.02.

Current Ratio	4.00
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,064.44

Financial Efficiency

Return on equity (ROE) is -98.60% and return on invested capital (ROIC) is -189.15%.

Return on Equity (ROE)	-98.60%
Return on Assets (ROA)	-73.40%
Return on Capital (ROIC)	-189.15%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.83% in the last 52 weeks. The beta is 1.52, so CGTX's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	+2.83%
50-Day Moving Average	2.00
200-Day Moving Average	1.76
Relative Strength Index (RSI)	44.95
Average Volume (20 Days)	148,626

Short Selling Information

The latest short interest is 180,713, so 0.45% of the outstanding shares have been sold short.

Short Interest	180,713
Short Previous Month	210,614
Short % of Shares Out	0.45%
Short % of Float	0.53%
Short Ratio (days to cover)	0.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-55.85M
Pretax Income	-28.77M
Net Income	-28.77M
EBITDA	-28.49M
EBIT	-28.74M
Earnings Per Share (EPS)	-$0.92

Full Income Statement

Balance Sheet

The company has $34.67 million in cash and $668,000 in debt, giving a net cash position of $34.00 million or $0.85 per share.

Cash & Cash Equivalents	34.67M
Total Debt	668,000
Net Cash	34.00M
Net Cash Per Share	$0.85
Equity (Book Value)	28.86M
Book Value Per Share	0.72
Working Capital	28.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.56 million and capital expenditures -$106,000, giving a free cash flow of -$20.66 million.

Operating Cash Flow	-20.56M
Capital Expenditures	-106,000
Free Cash Flow	-20.66M
FCF Per Share	-$0.61

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.95%
Shareholder Yield	-15.95%
Earnings Yield	-39.46%
FCF Yield	-28.34%

Analyst Forecast

The average price target for CGTX is $9.17, which is 403.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.17
Price Target Difference	403.85%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-2.84%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2